Skip to main content
Back to feed
MarketsSingle-sourceLow
2.1

Polpharma acquires Biofarm for 257 million euros to enter Romanian pharmaceutical market

Polish pharmaceutical group Polpharma has completed the acquisition of Romanian manufacturer Biofarm for 257 million euros. This transaction marks Polpharma's entry into the Romanian market, with stated intentions to expand the local product portfolio.

Ziarul Financiarabout 12 hours agoPL, ROCredibility 18%View source

Score Breakdown

Mosaic Score2.1
Confidence0.9
Significance0.1
Source credibility0.2

Intelligence Tags

#pharma#m&a#romania#poland#investment

Locations

Romania

Entities

country
Source

Related signals

8 found